10 Years of Infliximab: Long-Term Efficacy Outcome of 430 Crohn's Disease Patients in a Tertiary Referral Center

被引：0
|
作者：
Eshuis, Emma J.
te Braake, Frans W.
Ponsioen, Cyriel
Bartelsman, Joep F.
Bemelman, Willem
Stokkers, Pieter
机构：
来源：
GASTROENTEROLOGY | 2010年 / 138卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
W1290
引用
收藏
页码：S692 / S692
页数：1
相关论文
共 50 条
  • [1] 10 Years of Infliximab: Long-Term Safety Outcome of 430 Crohn's Disease Patients in a Tertiary Referral Center
    Eshuis, Emma J.
    te Braake, Frans W.
    Ponsioen, Cyriel
    Bartelsman, Joep F.
    Bemelman, Willem
    Stokkers, Pieter
    GASTROENTEROLOGY, 2010, 138 (05) : S674 - S674
  • [2] Long-term outcome and adverse events in Crohn's disease patients treated with infliximab at a single tertiary referral center over 9 years
    Milestone, Andrew N.
    Bullas, Dominic C.
    Hart, Ailsa L.
    Kamm, Michael A.
    Arebi, Naila
    GASTROENTEROLOGY, 2008, 134 (04) : A348 - A348
  • [3] Long-term outcome of Crohn's disease patients treated with infliximab
    Chen, B. L.
    Lv, S. C.
    Feng, T.
    Li, M. Y.
    Rao, P. S.
    Zeng, Z. R.
    Hu, P. J.
    Chen, M. H.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S245 - S245
  • [4] EFFICACY AND SAFETY OF INFLIXIMAB IN THE LONG-TERM IN CROHN'S DISEASE
    Fries, W.
    Privitera, A. C.
    Lo Presti, M. A.
    Mastronardi, M.
    Cappello, M.
    Grossi, L.
    Lauria, A.
    Principi, M.
    Della Valle, N.
    Buccianti, N.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S134 - S134
  • [5] Ten Years of Infliximab for Crohn's Disease: Outcome in 469 Patients from 2 Tertiary Referral Centers
    Eshuis, Emma J.
    Peters, Charlotte P.
    van Bodegraven, Adriaan A.
    Bartelsman, Joep F.
    Bemelman, Willem
    Fockens, Paul
    D'Haens, Geert R. A. M.
    Stokkers, Pieter C. F.
    Ponsioen, Cyriel Y.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (08) : 1622 - 1630
  • [6] Long-term Outcomes of High versus Low Anti-infliximab Antibody Titers in Patients with Crohn's Disease: A Tertiary Referral Center Experience
    Fessehaie, Nathaniel
    Beschloss, Alexander
    Nimgaonkar, Vivek
    Tan, Erik X.
    Travis, Daniel
    Lichtenstein, Gary
    Osterman, Mark
    Bhattacharya, Abhik
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S420 - S420
  • [7] Comparison of long-term outcomes of infliximab with adalimumab in biologic naive patients with Crohn's disease: a tertiary referral center 13-year experience
    Yuksel, I.
    Durak, M. B.
    Kilic, V.
    Kivrakoglu, F.
    Kosar, K.
    Erdogan, C.
    Alkan, A.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S525 - S526
  • [8] Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease
    Baert, F
    Noman, M
    Vermeire, S
    Van Assche, G
    D'Haens, G
    Carbonez, A
    Rutgeerts, P
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07): : 601 - 608
  • [9] Long-term outcome of treatment with infliximab in 440 crohn's disease patients: Results from a single center cohort
    Schnitzler, Fabian
    Fidder, Henna
    Ferrante, Marc
    Noman, Maja
    Van assche, Geri
    Hoffman, Ilse
    Vermeire, Severine
    Rutgeerts, Paul
    GASTROENTEROLOGY, 2007, 132 (04) : A145 - A145
  • [10] Crohn's disease outcome in patients under azathioprine: A tertiary referral center experience
    Magro, Fernando
    Santos-Antunes, Joao
    Vilas-Boas, Filipe
    Rodrigues-Pinto, Eduardo
    Coelho, Rosa
    Ribeiro, Orquidea Silva
    Lopes, Susana
    Macedo, Guilherme
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (07): : 617 - 625
12345